Uniondale, NY, October 9, 2002 - Twenty percent of consumers say that direct-to-consumer advertising prompted them to call or visit their doctor to discuss the prescription drug they saw advertised, according to PharmTrends174 , a patient-level syndicated tracking study of consumer behavior by world-leading market research organization Ipsos-NPD.
The PharmTrends174 August survey also found that 50% of consumers had seen advertising for prescription products in the previous 12-months, up from 47% in its February survey. PharmTrends174 Direct-to-Consumer Response Tracker surveyed 25,182 respondents, a sample representative of the US population. The study, launched in February, tracks consumer awareness of and reaction to direct-to-consumer advertising by the pharmaceutical industry. It also found that:
- 22% percent of respondents stated that direct-to-consumer advertising made them aware of potential drug options for their condition(s).
- 12% of respondents stated that direct-to-consumer advertising prompted them to ask their doctor about the prescription drug they saw advertised.
- 10% stated that drug advertising reminded them to refill a prescription.
- 5% said they were prompted to switch from their current drug therapy to a different drug that they had seen advertised.
"Our results show that prescription drug advertising pays off not only by enhancing branded prescription drug awareness and encouraging trial use, but also by reminding patients to fill or refill their prescriptions," said Fariba Zamaniyan, Director, Ipsos PharmTrends174.
Certain categories have higher advertisement recall among consumers. The top-ranking categories for advertisement recall levels include:
TOP CATEGORIES FOR PRESCRIPTION BRAND DRUG RECALL Based on % of buyers that recalled an ad for a prescription brand within that category
Certain brand name prescription drugs present high levels of advertisement recall among their purchasers, PharmTrends174 reports. Viagra tops the list for ad recall: 98% of purchasers of Viagra recalled seeing an ad for the product. Celebrex, with an ad recall of 78% of buyers, closes that top ten list.
TOP TEN PRESCRIPTION BRAND DRUGS BY AD RECALL LEVELS Rank based on % of buyers that recalled seeing an advertisement for the prescription brand that they purchased
"With more `blockbuster' products going off-patent over the next few years, it will be more important than ever for drug manufacturers to raise awareness of existing and upcoming formulations," Zamaniyan added.
"Consumers seem receptive to drug promotions, particularly if they, or a family member, have an ailment. Drug companies who use direct-to-consumer advertising effectively -- to make consumers more-informed buyers and build long-term loyalty -- will be the most successful in extending the life of their products." concluded Ms. Zamaniyan.
Ipsos PharmTrends174 Methodology Each month, PharmTrends174 syndicated tracking service captures both prescription fulfillment and over-the-counter purchasing data through a longitudinal and continuous consumer panel of 16,000 households that is representative of the U.S. census composition. Each month, panelists report their prescription and over-the-counter purchases for the treatment of a full spectrum of conditions (general and specific). The monthly tracking began in 1997.
InstaVue Survey Methodology During the month of August, 2002, Ipsos PharmTrends174 interviewed a representative sample of over 25,000 adults 18+ years of age nationwide using InstaVue, an omnibus mail survey. The study was conducted and paid for by Ipsos PharmTrends174.
- For more information on this release, please contact:
Fariba Zamaniyan, Director Ipsos PharmTrends174
Quality and inequality characterize U.S. healthcare in global survey
Americans are generally more satisfied with the quality of their healthcare than people in other countries, but they hold more unfavorable views about their system’s affordability and equality of treatment; cost ranks as the #1 problem facing the U.S. healthcare system
[WEBINAR] LGBT+ Pride 2021: Insights and Implications
Join us for a complimentary webinar featuring new research insights from Ipsos’ LGBT+ Pride 2021 Survey – a global study of nearly 20,000 interviews of adults from 27 countries – and a discussion of their implications by a panel of experts from leading academic, advocacy, and business organizations.